158 related articles for article (PubMed ID: 15655407)
21. Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials.
Geng CJ; Liang Q; Zhong JH; Zhu M; Meng FY; Wu N; Liang R; Yuan BY
BMJ Open; 2015 Jun; 5(6):e007258. PubMed ID: 26038356
[TBL] [Abstract][Full Text] [Related]
22. Ibandronate: efficacy in the treatment of metastatic bone disease.
Diel IJ
Future Oncol; 2005 Oct; 1(5):593-607. PubMed ID: 16556036
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates for prevention of postmenopausal osteoporosis.
Ravn P
Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
[TBL] [Abstract][Full Text] [Related]
24. [Ibandronate: keep life in motion].
Longo F; Mansueto G
Tumori; 2004; 90(2):9-16. PubMed ID: 15237599
[No Abstract] [Full Text] [Related]
25. Efficacy and safety of ibandronate in the treatment of neoplastic bone disease.
Pecherstorfer M
Expert Opin Pharmacother; 2004 Nov; 5(11):2341-50. PubMed ID: 15500381
[TBL] [Abstract][Full Text] [Related]
26. Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.
Bauss F; Russell RG
Osteoporos Int; 2004 Jun; 15(6):423-33. PubMed ID: 15205712
[TBL] [Abstract][Full Text] [Related]
27. [The role of bisphosphonates of adjuvant therapy in breast cancer].
Gálvez-Muñoz E; Rodríguez-Lescure Á
Med Clin (Barc); 2010 Jun; 135(2):70-4. PubMed ID: 20022069
[TBL] [Abstract][Full Text] [Related]
28. Ibandronate is effective in preventing skeletal events in patients with bone metastases from colorectal cancer.
Heras P; Karagiannis S; Kritikos K; Hatzopoulos A; Mitsibounas D
Eur J Cancer Care (Engl); 2007 Nov; 16(6):539-42. PubMed ID: 17944770
[TBL] [Abstract][Full Text] [Related]
29. The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia.
Neville-Webbe Hl; Coleman RE
Palliat Med; 2003 Sep; 17(6):539-53. PubMed ID: 14526888
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonates for malignancy-related bone disease: current status, future developments.
Body JJ
Support Care Cancer; 2006 May; 14(5):408-18. PubMed ID: 16450087
[TBL] [Abstract][Full Text] [Related]
31. Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
Body JJ; Diel IJ; Lichinitser MR; Kreuser ED; Dornoff W; Gorbunova VA; Budde M; Bergström B;
Ann Oncol; 2003 Sep; 14(9):1399-405. PubMed ID: 12954579
[TBL] [Abstract][Full Text] [Related]
32. Use of bisphosphonates in patients with metastatic bone disease.
Berenson JR; Lipton A
Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935
[TBL] [Abstract][Full Text] [Related]
33. [Biosphonates in oncology].
Paule B; Clerc D; Brion N
Presse Med; 2000 Apr; 29(13):723-9. PubMed ID: 10797827
[TBL] [Abstract][Full Text] [Related]
34. Treatment with ibandronate preserves bone in experimental tumour-induced bone loss.
Kurth AH; Kim SZ; Sedlmeyer I; Hovy L; Bauss F
J Bone Joint Surg Br; 2000 Jan; 82(1):126-30. PubMed ID: 10697328
[TBL] [Abstract][Full Text] [Related]
35. Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.
Kurth AA; Kim SZ; Sedlmeyer I; Bauss F; Shea M
Bone; 2002 Jan; 30(1):300-6. PubMed ID: 11792601
[TBL] [Abstract][Full Text] [Related]
36. Renal safety of ibandronate.
Jackson GH
Oncologist; 2005; 10 Suppl 1():14-8. PubMed ID: 16264108
[TBL] [Abstract][Full Text] [Related]
37. Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.
Neudert M; Fischer C; Krempien B; Bauss F; Seibel MJ
Int J Cancer; 2003 Nov; 107(3):468-77. PubMed ID: 14506749
[TBL] [Abstract][Full Text] [Related]
38. Ibandronate: pharmacology and preclinical studies.
Russell RG
Bone; 2006 Apr; 38(4 Suppl 1):S7-12. PubMed ID: 16531132
[TBL] [Abstract][Full Text] [Related]
39. Clinical value of bisphosphonates in cancer therapy.
Lüftner D; Henschke P; Possinger K
Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
[TBL] [Abstract][Full Text] [Related]
40. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
